CWD
ABBV icon

Clarity Wealth Development’s AbbVie ABBV Stock Holding History

Clarity Wealth Development’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-997
Closed -$228K – 45
2025
Q4 		$228K Hold
997
– – 0.19% 41
2025
Q3 		$227K Sell
997
-115
-10% -$23.4K 0.2% 42
2025
Q2 		$206K Sell
1,112
-66
-6% -$12.3K 0.21% 43
2025
Q1 		$230K Sell
1,178
-8
-0.7% -$1.55K 0.26% 38
2024
Q4 		$218K Buy
+1,186
New +$218K 0.24% 42

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clarity Wealth Development's ABBV Position: Q1 2026 in Review

Clarity Wealth Development sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 997 shares — an estimated $228K sold.

Clarity Wealth Development first reported a position in ABBV in Q4 2024 and held it in 5 quarters. The position peaked at $230K in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Clarity Wealth Development reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Clarity Wealth Development sold 997 AbbVie shares in Q1 2026, an estimated $228K.
  • Clarity Wealth Development first reported a position in AbbVie in Q4 2024 and held it in 5 quarters.
  • Clarity Wealth Development's AbbVie position peaked at $230K in Q1 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Clarity Wealth Development's 13F filing for Q1 2026, filed 22 Apr 2026.